Icahn School Of Medicine At Mount Sinai
Carboplatin added to paclitaxel confers EFS benefit in triple-negative breast cancer
The addition of carboplatin to paclitaxel improved pathologic complete response and EFS with no increase in secondary malignancies among patients with triple-negative breast cancer, randomized phase 3 trial results showed.
Edoxaban ‘plausible alternative to warfarin’ to treat AF after TAVR
In the ENVISAGE-TAVI AF trial, edoxaban was noninferior to vitamin K antagonists for adverse clinical events and was associated with increased major bleeding in patients with AF who underwent transcatheter aortic valve replacement.
European valvular heart disease guideline parses who should get TAVR or surgical AVR
The new European Society of Cardiology/European Association for Cardio-Thoracic Surgery valvular heart disease guideline includes updated recommendations on which patients should get transcatheter or surgical aortic valve replacement.
'Consequence and cause': Amyloidosis in the rheumatic diseases
The spectrum of conditions under the amyloidosis umbrella can present in myriad ways in patients with rheumatic diseases, with several possible complications, according to data from the 2021 Congress of Clinical Rheumatology-East.
Early treatment via mobile stroke units yields better outcomes vs. ‘drip and ship’
Among patients with stroke who presented early after symptom onset, those treated by a mobile stroke unit were more functionally independent at 90 days compared with those treated with the “drip and ship” method, researchers reported.